baber/WOPTO huggingface dataset:
Patent FI-823042-L (FI)
Inventor: BIERNOTH GERHARD
IPC: C11B7/00
Filed: 1982-09-03
Abstract: A process for producing a mixture of triglycerides displaying butter-like properties by fractionating fats with a liquefied gas or a gas under supercritical conditions. Said mixture of triglycerides predominantly consists of triglycerides with a carbon number ranging from 24 to 42 and can be used as one of the fat components of a margarine fat blend in order to improve its butter-like properties.
Patent IE-35500-L (IE)
Title: Phenylthiocarbamates
IPC: A01N47/22
Filed: 1971-08-10
Abstract: 1362705 Phenylthiocarbamates SCHERING AG 27 July 1971 [20 Aug 1970] 35129/71 Heading C2C The invention comprises compounds of the general formula in which R 1 is a C 1-5 alkyl group, R 2 is a hydrogen atom or a C 1-5 alkyl group, R 3 is a substituted or unsubstituted aliphatic, cycloaliphatic or aromatic hydrocarbon group or R 2 and R 3 together with the adjacent nitrogen atom represent a heterocyclic ring which may contain a further hetero atom. They may be prepared by (i) reacting a compound of the general formula with (a) a carbamoylchloride of the general formula or with (b) phosgene to form a chloroformic acid ester which is reacted with an amine of the general formula or (c) when R 2 is hydrogen, with an isocyanate of the general formula or by (ii) reacting a compound of the general formula with a chlorothioformic acid-O-alkyl ester of the general formula The compounds of the invention may be used as active ingredients in herbicidal compositions.
[GB1362705A]
Patent IE-831098-L (IE)
Title: Use of a protoberberine alkaloid and composition containing¹same
IPC: A61K31/47
Filed: 1983-05-12
Abstract: A composition containing a protoberberine alkaloid or its salt which is effective to increase the contractility of the mammalian heart as shown by a positive inotropic effect (as evidenced by an increased dP/dT and dF/dT), accompanied by at least one the following symptoms: improved aortic blood flow, decrease in heart rate, decrease in systemic arterial pressure, reduction of afterload of the left ventricle, decrease in preload of the left ventricle, decrease in calculated vessel peripheral resistance, decrease in mean arterial pressure and freedom of arrhythmias, and its method of use.
[WO8303970A1]
Patent IE-791100-L (IE)
Title: Cement lining of pipes
IPC: B28B21/58
Filed: 1979-08-08
Abstract: A pipe lining apparatus includes a distributor head which throws cement mortar centrifugally against the interior of a pipe, a trowel which smooths the cement mortar and a liquid coating spray applicator which applies a curing control substance to the trowelled lining. The spray applicator comprises an air atomizing device which produces a very fine coating spray and blows it onto the freshly applied mortar lining without disturbing the lining. Also, in one embodiment the coating spray application is mounted to swing laterally with the trowel so as to be maintained centrally in the pipe.
Patent IE-781163-L (IE)
Title: Sustained release of veterinary medicaments
IPC: A61D7/00
Filed: 1978-06-08
Abstract: Sustained release composition comprising a water soluble veterinary medicament dispersed in a sheet of water insoluble polymer, which sheet is of a size and composition such that it is capable of being constrained in a position which allows oral administration and is, in the rumen, capable of moving relative to this position to retain the composition therein.
[US4228149A]
Patent IE-37977-L (IE)
Title: Norbornane amines
IPC: C07C211/38
Filed: 1973-08-07
Abstract: The present invention is concerned with norbornane derivatives and a process for the manufacture thereof.
[US3884976A]
Patent IE-33397-L (IE)
Title: Tenderization of meat.
IPC: A23L13/70
Filed: 1969-10-01
Abstract: A process for mechanically tenderizing meat for human consumption after the carcass has been separated into primal cuts which have muscle fibers arranged substantially in the same direction, by applying pressure within the range of 50 to 100 pounds per square inch against two opposing surfaces of the meat cut perpendicularly to the direction of the muscle fibers, and preventing expansion of the cut in a direction across the fibers while permitting deformation in the direction of the muscle fibers. This invention provides apparatus for accomplishing the above process which includes a container having a width substantially the same as that of the meat cut measured across the grain and a length greater than the length of the cut measured in the direction of the fibers. A compressing plug presses the meat in the container causing the meat to deform in the direction of the fibers but not across the grain thereby disrupting and separating the connective tissue from the muscle fibers and rendering the meat more tender for human consumption. A pair of compressing rolls forming a nip is advantageously used on cuts having a thickness less than 2 inches.
[US3635731A]
Patent IE-901498-L (IE)
Title: Benzothiazolinone derivatives
IPC: A61P25/04
Filed: 1990-04-27
Abstract: Compounds of general formula (I): (I) in which: R1 represents a hydrogen atom or a lower alkyl group, R2 represents a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted thienyl, furyl, pyrrolyl or pyridinyl group, X represents a hydrogen atom, Y represents a hydroxyl group, or else X and Y together represent an oxygen atom, their enantiomers, diastereoisomers and epimers. Medicaments.
Patent IE-881505-L (IE)
Title: (Substituted aralkyl)heterocyclic compounds
IPC: C07D249/08
Filed: 1988-05-19
Abstract: A (substituted-aralkyl)heterocyclic compound of the formula I <CHEM> wherein R<1> is an azido, carbamoyl, cyano, formyl, hydroxy or nitro radical, a 1-6C 1-hydroxyalkyl, alkoxy, alkylcarbamoyl, alkylthio, alkylsulphinyl or alkylsulphonyl radical, a 2- cyanoethyl radical, optionally bearing one to four 1-6C alkyl substituents, or a 2-6C alkanoyl, halogenoalkanoyl, alkanoyloxy, alkanoylamino, dialkylcarbamoyl or alkoxycarbonyl radical; R<2> and R<3>, which may be the same or different, are each a hydrogen atom, a 1-6C alkyl, deuterioalkyl or halogenoalkyl radical, or a phenyl or phenyl(1-6C alkyl) radical, in each of which the phenyl may optionally bear one or more substituents; or R<2> and R<3>, together with the carbon atom to which they are attached, may form a 3- to 6-membered ring; or R<1>R<2>R<3>C-is a 1,1-dicyanoethyl or trifluoromethylsulphonyl radical; R<4> is a hydrogen or halogen atom, a cyano or nitro radical or a 1-6C alkyl or halogenoalkyl radical; R<5> has any of the values defined above for the group R<1>R<2>R<3>C but is not necessarily the same as R<1>R<2>R<3>C, or has any of the values defined above for R<4> but is not necessarily the same as R<4>, or is a carbamoyl, 1-pyrrolidinyl-carbonyl, piperidinocarbonyl, morpholinocarbonyl or nitro radical, a 1-6C alkoxy or halogenoalkoxy radical or a 2-6C alkanoyl or alkoxy-carbonyl radical; A is a methylene or ethylene radical optionally bearing one or more substituents selected from deuterium and halogen atoms, carbamoyl, cyano and hydroxy radicals, 1-6C alkyl and alkoxy radicals, and 2-6C alkanoyloxy radicals provided that when A is linked to R<6> through a nitrogen atom thereof, it may not bear a hydroxy, alkoxy or alkanoyloxy substituent on the carbon atom adjacent to such nitrogen atoms; and R<6> is a 1H-1,2,4- triazol-1-yl, 4H-1,2,4-triazol-4-yl, 1H-imidazol-1-yl, 5-cyano-1H-imidazol-1-yl, 3-pyridyl or 5-pyrimidinyl radical, or a 1H-imidazol-1-yl radical, bearing at the 5-position thereof a 1-6C alkyl substituent which is itself optionally substituted by one or more carbamoyl, cyano, hydroxy or 2-6C alkoxycarbonyl radicals; and provided that when R<2>, R<3>, R<4> and R<5> are hydrogen, A is a methylene radical and R<6> is a 3-pyridyl radical, R<1> is not a cyano, hydroxy or hydroxymethyl radical, and when R<1> is a hydroxy radical, R<3>, R<4> and R<5> are hydrogen, A is a methylene radical and R<6> is 3-pyridyl, R<2> is not a methyl or a 2-chloro-1-methylethyl radical, and provided that when R<1> is a methoxycarbonyl radical, R<2>, R<3>, R<4> and R<5> are hydrogen and A is a methylene radical, R<1> is not a 1H-imidazol-1-yl radical; and the pharmaceutically acceptable acid addition salts thereof.
Patent IE-781510-L (IE)
Title: Treatment of swine dysentery
IPC: A23K20/195
Filed: 1978-07-26
Abstract: Swine dysentery may be treated or prevented by administering to a swine an effective amount of pseudomonic acid, a nontoxic salt thereof or nontoxic ester thereof.
[US4186206A]
Patent IE-791597-L (IE)
Title: Glaucine lactate salts
IPC: A61P25/04
Filed: 1979-08-20
Abstract: Lactate salts of l-glaucine and d,l- glaucine having antitussive and analgesic properties, which additionally have good stability and palatability.
[GB2028323A]
Patent IE-41653-L (IE)
Title: Air pore lacquers containing white pigments and/or white¹fillers
IPC: C09D5/00
Filed: 1975-08-15
Abstract: An air pore lacquer comprising a solvent, a binder and at least one additive which is a white pigment or white filler, the additive having an average particle size Dzv which is at least about 10% smaller than the optimum average particle size for the same binder free from air pores. When the additives are pigments they are preferably 20 to 50% smaller, and when they are fillers preferably 20 to 80% smaller, than the optimum particle size for the air pore-free binder. Rutile and anatase TiO2 are preferred.
[US4249953A]
Patent IE-821850-L (IE)
Title: Autoxidisable coating compositions
IPC: C08F32/00
Filed: 1982-07-30
Abstract: An improved autoxidizab!e coating and/or impregnating composition comprises:(1) from 35 to 80 parts by weight, based on the total weight of components (1), (2) and (3), of a film-forming component comprising one or more drying oil and/or alkyd resin,(2) from 10 to 50 parts by weight, based on the total weight of components (1), (2) and (3). of polymer having a number average molecular weight (Mn) of from 1,000 to 50,000 and containing:(a) from 40% to 100% by weight of units of dicyclopentenyl methacrylate and/or dicyclopentenyl-oxyalkyl methacrylate, and(b) from 60% to 0% by weight of units of at least one other compatible monomer,(3) from 0 to 40 parts by weight, based on the total weight of components (1), (2) and (3), of reactive non-volatile diluent monomer, and(4) sufficient polyvalent metal salt(s) or complex(es) to catalyse the oxidative curing of components (1), (2) and (3), the total of components (1), (2) and (3) being 100 parts by weight.
Patent IE-44294-L (IE)
Title: 5-thiazole methane amine derivatives
IPC: C07D277/22
Filed: 1976-09-13
Abstract: A 5-thiazole-methane-amine selected from the group consisting of (1) compounds having the formula ##STR1## wherein R.sub.1 represents an alkyl having from 1 to 6 carbon atoms and R.sub.2 and R.sub.3 represent members selected from the group consisting of hydrogen, alkyl having from 1 to 6 carbon atoms, hydroxyalkyl having 1 to 6 carbon atoms, and, taken together, alkylene having up to 5 carbon atoms, azaalkylene having up to 4 carbon atoms, alkylalkylene having up to 5 carbon atoms in the alkylene and 1 to 4 carbon atoms in the alkyl, and alkylazaalkylene having up to 4 carbon atoms in the azaalkylene and 1 to 4 carbon atoms in the alkyl which may be in any position, and (2) its acid addition salts with non-toxic, pharmaceutically-acceptible acids; as well as processes for the preparation of the compounds and a process for use of the compounds as an antilipolytic agent.[US4108994A]
Patent IE-38550-L (IE)
Title: Method of making tablets
IPC: A61K33/00
Filed: 1973-11-27
Abstract: 1450536 Sustained release tablets containing lithium carbonate DELANDALE LABORATORIES Ltd 20 Nov 1973 54671/72 Addition to 1209093 Heading A5B Sustained release pharmaceutical tablets for the treatment of manic depressive states, comprising powdered lithium carbonate; a sustained release agent comprising a mixture of glyceryl mono-, di- and tri-esters of one or mere C 16-18 straight chain saturated fatty acids and one or more excipients, are prepared by coating a mixture of powdered lithium carbonate and one or more excipients with the sustained release agent, granulating the mixture using about (11.55 to 24.5 p) litres of water per 100 kg lithium carbonate where p is the bulk density of the lithium carbonate in grams per c.c., screening to form a granulate whose particles are all less than 12 BS Mesh, from 20 to 30% of which have particle sizes in the range of from 12 BS to 60 BS Mesh and from 70 to 80% of which have a particle size below 60 BS Mesh, and compressing the granulate into tablets. The tablets may comprise a filler e.g. mannitol, a binding agent e.g. gum acacia and a lubricant e.g. magnesium stearate. The tablets preferably contain 9.5 to 11.4 parts by weight of the mixture of glyceryl esters per 100 parts by weight of lithium carbonate. Preferably the sustained release agent is added in alcohol solution and at 68C or higher, the powdered lithium carbonate and filler being pre-heated to about this temperature before adding the solution.
[GB1450536A]
Patent IE-802514-L (IE)
Title: N-substituted 2-methylnaphthylamides
IPC: C07D317/28
Filed: 1980-12-03
Abstract: N-Substituted 2-methylnaphthylamides of the general formula   <IMAGE> where R1 is   <IMAGE>   R3 being hydrogen or alkoxy, or R1 is <IMAGE>   R4 and R5 being unsubstituted or substituted alkyl, or R4 and R5 together forming a heterocyclic ring which contains two oxygen atoms and is unsubstituted or substituted by alkyl or aryl, R2 is alkyl which is unsubstituted or substituted by halogen, alkoxy, imidazolyl, pyrazolyl or oxo (=O), or is alkenyl, alkynyl, cycloalkenyl or alkoxy, or substituted or unsubstituted phenyl, or substituted or unsubstituted hetaryl and X is hydrogen, methyl or halogen, fungicides containing these compounds, and processes for the preparation of the compounds.
Patent IE-852892-L (IE)
Title: Glass sheet processing
IPC: C03B35/14
Filed: 1985-11-18
Abstract: A glass sheet processing system including topside transfer apparatus (12) for transferring glass sheets during processing. The transfer apparatus (12) supports glass sheets at a downwardly facing surface (36) by a vacuum drawn through a first set of holes (38) in the surface and by pressurized gas supplied through a second set of holes (40) in the surface. The topside transfer apparatus (12) has particular utility when utilized in a glass sheet forming system (10, 10') to transfer a heated glass sheet from a heating conveyor to a curved mold for forming. In addition, the topside handling apparatus has other uses such as conveying glass sheets during heating prior to processing, supporting a heated glass sheet on a deformable platen for forming, and loading a glass sheet onto a conveyor for processing.
[US4578103A]
Patent IE-832954-L (IE)
Title: Hollow fiber plasmapheresis module.
IPC: A61M1/34
Filed: 1983-12-15
Abstract: Hollow fiber plasmapheresis module and process, said module comprising hollow fibers having cell-retaining pores and an effective length (L) to lumen diameter (D) ratio L/D not greater than 16,400 cm-1 D (L and D being in centimeters) within a housing having a blood inlet for conducting blood to the fibers, an outlet for conducting exit (plasma-depleted) blood from the fibers, and a plasma outlet for conducting plasma out of the module.
[US4668399A]
Patent NO-763451-L (NO)
Inventor: EGGLER J F
IPC: C07C401/00
Filed: 1976-10-08
Abstract: Fremgangsmåte for fremstilling av ll-dasoksy-13,14-dehydro-16-aryl-w-tetranorprostaglandiner.
Patent NO-820314-L (NO)
Inventor: MICHEL MANFRED
IPC: B05C17/00
Filed: 1982-02-02
Abstract: 1. A hand mixing gun for the simultaneous extrusion of two low to highly viscous liquids out of a cartridge device containing two liquids separately, in which cartridge device a discharge piston (2) is displaceable for each liquid, with a receiver for the cartridge device, a mixing tube (4) to which the outlets of the cartridge device can be connected and which has an outlet nozzle (6) for the mixed liquids, two piston rods (3) which can be pushed into the cartridge device from the side opposite to the outlets of the cartridge device to push the discharge pistons (2) forwards and a drive motor (9) to move the piston rods (3), wherein the cartridge receiver is adapted to store two cartridges side by side, characterized in that a change-speed gear (8) is provided, which permits the drive of the two discharge pistons (2) at feed speeds, the ratio of which to one another can be preset in order to produce a desired mixing proportion of the two liquids.
Patent NO-840524-L (NO)
Inventor: NICHOLSON MYRON DONALD
IPC: A23L5/41
Filed: 1984-02-13
Abstract: A process and composition for inhibiting the formation of discoloration and black spots upon a cellulose food casing treated with a liquid smoke solution derived from natural wood and containing smoke color, odor and flavor constituents, comprising contacting the food casing with an agent having the ability to prevent the progressive oxidation of metals.
Patent NO-841764-L (NO)
Inventor: BIRKETT KEVIN
IPC: C09D5/08
Filed: 1984-05-03
Abstract: Corrosion inhibition of metals (especialy iron, zinc, copper, tin and aluminium and in particular mild steel and the zinc surface of galvanised steel) is provided by treatment with an optionally substituted 2-hydroxy-5-alkylbenzaldoxime wherein the 5-alkyl group contains from 7 to 13 carbon atoms. The benzaldoxime may be applied directly or as a solution in an organic solvent or as an aqueous emulsion. The benzaldoxime may be formulated in a surface coating composition.
Patent NO-842921-L (NO)
Inventor: BIETTI GIUSEPPE
IPC: C07D233/64
Filed: 1984-07-17
Abstract: Object of the present invention are new pharmacologically active amidine derivatives of 2-substituted 4-phenylimidazole of formula 
<CHEM>
 in which R representa a linear or branched alkyl group, a hydroxy group, a C1-3 alkoxy group, a mercapto group, C1-3 alkylthio group, a halogen atom, a C1-3 alkylsulfinyl or alkylsulfonyl group, a sulfamoyl group, an amino group which may be substituted by one or two alkyl groups having 1 to 3 carbon atoms, an acylamino group or a phenyl group; R1 and R2, which may be the same or different, represent a hydrogen atom or an alkyl group; R3 represents a linear or branched alkyl group containing optionally one heteroatom such as an oxygen, a sulphur or a nitrogen atom, an alkenyl group, an alkynyl group, a cyano group, an aryl or an aralkyl group optionally substituted, a cycloalkyl or cycloaliphatic alkyl group, a substituted or unsubstituted heterocyclilalkyl or heterocyclic group; R4 represents a hydrogen atom, a C1-3 alkyl or alkoxy group, a halogen atom, a cyano or carbamoyl group, tautomeric forms thereof and acid addition salts thereof. 
<??>Processes for the preparation of the compounds of formula (1) and their intermediates as well as the pharmaceutical compositions containing them are also object of this invention. 
<??>The new compounds are H2-receptor blocking agents which inhibit the gastric acid secretion and are useful antiulcer agents.
Patent NO-843799-L (NO)
Inventor: GRAU ULRICH
IPC: A61P5/00
Filed: 1984-09-21
Abstract: 1. Claims for the Contracting States : BE CH DE FR GB IT LI LU NL SE A medicament having a delayed action for the treatment of diabetes mellitus, comprising at least one insulin derivative of the formula I see diagramm : EP0137361,P16,F1  in which R**1 denotes H or H-Phe R**30 represents the radical of a neutral, genetically codable L-aminoacid whose OH group, where present, can be free or protected by a physiologically acceptable group, and R**31 denotes a physiologically acceptable neutral group blocking the carboxyl group, with the exception of des-B30 human insulin Leu**B30 -NH2 and des-B30 human insulin Gly**B30 -NH2 and des-B30 human insulin Phe**B30 -NH2 and a pharmaceutically acceptable carrier. 1. Claims for the Contracting State : AT A process for the preparation of a medicament having a delayed action for the treatment of diabetes mellitus, which comprises bringing into a suitable dosage form at least one insulin derivative of the formula I  see diagramm : EP0137361,P17,F1  in which R**1 denotes H or H-Phe R**30 represents the radical of a neutral, genetically codable L-aminoacid whose OH group, where present, can be free or protected by a physiologically acceptable group, and R**31 denotes a physiologically acceptable neutral group blocking the carboxyl group, with the exception of des-B30 human insulin Leu**B30 -NH2 and des-B30 human insulin Gly**B30 -NH, and des-B30 human insulin Phe**B30 -NH2 Phe**B30 -NH2 and a pharmaceutically acceptable carrier.
Patent NO-853511-L (NO)
Title: 7-okso-4-tia-1-azabicyklo(3,2,0)hept-2-en-derivater.
Inventor: BARKER ANDREW JOHN
IPC: C07D499/88
Filed: 1985-09-09
Abstract: Forbindelse av formel (). hvor R^" er en alkylgruppe substituert med en eller flere substituenter, og estere derav ved 2-karboJcsygruppen og/eller ved 8-hydroksygruppen; og salter derav. Forbindelser av formel (I) har antibakteriell virkning. Forskjellige mellomprodukter er beskrevet. Denne forbindelsen av formel (I), eller en ester ved 2-karboksygruppen og/eller ved 8-hydroksygruppen eller et salt derav fremstilles ved å omsette en forbindelse av formel(II) eller av formel (IX)hvor R står for et hydrogenatom eller en karboksybeskyttelsesgruppe, står for en aktivert karboksylsyregruppe, \ R4 står for en alkylgruppe som inneholder 1-4 karbonatomer, eller en fenylgruppe som kan være usubstituert eller ] substituert, R står for en fenylgruppe eller en alkylgruppe sora inneholder fra 1-4 karbonatomer, og X står for et oksygen- eller svovelatom, med et amin av formel (III)slik at man får en forbindelse av formel (I) eller en ester derav av formel (a)
Patent NO-862171-L (NO)
Title: Fremgangsmaate ved fremstilling av et vanntett dekke, samt middel for utfoerelse av fremgangsmaaten.
Inventor: JENSEN IB ROER
IPC: D06N5/00
Filed: 1986-05-30
Abstract: Et arkmateriale (1) for fremstilling av et belegg omfatter kommuniserende trykkavlastende passasjer ved at det på en side er påført et stort antall separate, rektangulære soner (2) av et bitumenholdig bindemiddel modifisert med 5-40 vekt-% av en termoplastisk elastomer, en fremgangsmåte ved anvendelse av materialet er også vist.
Patent NO-881712-L (NO)
Inventor: BONANNO FRANCESCO
IPC: A47J31/44
Filed: 1988-04-20
Abstract: Apparatus apt to heat, emulsify, whip, harden, liquids of different types, particularly milk, chocolate, punch and the like, comprising : - a turbulence tube (2) to be immersed in the liquid to be treated the wall of which is provided with a calibrated hole (5), being able to act as an air inlet; and - a securing block (6) to be hermetically mounted on the top of said turbulence tube and terminating at its lower portion with a calibrated hole (4), said block being able to be coupled to a source of steam through coupling means.
Patent NO-883561-L (NO)
Title: Furanpolyoler, deres fremstilling og anvendelse av dem i polyuretaner.
Inventor: ROUX GABRIEL
IPC: C07D307/00
Filed: 1988-08-11
Abstract: Nye furanpolyalkoholer son erat de er reaksjonsprodukt: a) av et stoff valgt fra gruppen som omfattes av en polyalkohol, et monoamin eller et polyamin, hvor nevnte polyalkohol eller nevnte amin eventuelt inneholder minst en furansyklus; og blandinger derav; og b) av et kjedeforlengelses-middel som eventuelt inneholder minst én furansyklus som utgjøres av et organisk epoksyd, under den forutsetning at dette organiske epoksyd er et furanisk oksiran når nevnte stoff ikke inneholder noen furansyklus; med utelukkelse av 2,5-bis(hydroksymetyl)furan som eneste stoff når kjedeforlengel-sesmidlet ikke inneholder noen furansyklus. Disse furanpolyalkoholer anvendes ved fremstilling av polyuretanskum som har forbedrede egenskaper.
Patent NO-892642-L (NO)
Inventor: BORSTEL REID WARREN VON
IPC: A61P43/00
Filed: 1989-06-26
Abstract: Use of acyl derivatives of deoxyribonucleosides in manufacture of a medicament for enhancing haematopoesis or enhancing healing of bone marrow. <IMAGE>